BICO News Feed​

Discover the latest news from our business areas.
  • 8:28 am

The US senate has passed the FDA Modernization Act

Share on facebook
Share on twitter
Share on linkedin

The US Senate has passed the FDA Modernization Act with unanimous consent!

A massive stride in the acceptance of alternatives to animal models in drug discovery. Alternatives that capture human physiology better, that are more ethical, sustainable and most importantly, alternatives that can accelerate the discovery of life changing therapies. Alternatives that our bioprinters have proudly supported and enabled since our inception. Alternatives that we are committed to continuing to develop and democratize.
Learn more

More news

March 31, 2023 | Bico

Successful integration of BICO companies Mattek and Visikol
March 28, 2023 | Bico

Visikol’s Leaders Honored
February 27, 2023 | Scienion

BICO introduces new life sciences manufacturing platform integrating ABB Robotics technology
February 27, 2023 | Cellink

CELLINK and Nanyang Technological University jointly open a Research, Innovation and Development Lab focused on exploring bioprinting in critical use cases like regenerative medicine and drug discovery.
February 17, 2023 | Scienion

SCIENION UK: workshop on lateral flow and point-of-care devices
February 14, 2023 | Cellink

CELLINK Introduces DNA Studio 4 Vault, a bioprinting software developed to support our customers to adhere to Title 21 CFR Part 11 Electronic records and EudraLex – Volume 4 – Good Manufacturing Practice (GMP) guidelines – Chapter 4: Documentation
February 6, 2023 | Scienion

SCIENION expects to move to its new building in Wagner-Régeny-Straße in Berlin Adlershof in June 2023
January 5, 2023 | Dispendix

SLAS 2023
January 3, 2023 | Bico

Congress Approves Landmark Measure to Reduce Animal Testing
Load more